COAGULATION FACTOR IX RECOMBINANT HUMAN: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
1.3%
Female
98.7%
Male
Age Information
The average age of patients reporting adverse events with COAGULATION FACTOR IX RECOMBINANT HUMAN is 27.7 years.
Geographic Distribution
The majority of adverse event reports for COAGULATION FACTOR IX RECOMBINANT HUMAN originate from US.
Report Summary & Outcomes
1,066
Total Reports
1,066
As Primary/Secondary Suspect
20
Deaths Reported
167
Hospitalizations
6
Life-Threatening
2
Disabilities
Reporting Timeline
First adverse event report: 20110814. Most recent report: 20250901. View full timeline →